ID   RDH12_HUMAN             Reviewed;         316 AA.
AC   Q96NR8; B2RDA2; Q8TAW6;
DT   29-AUG-2003, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 3.
DT   10-MAY-2017, entry version 143.
DE   RecName: Full=Retinol dehydrogenase 12;
DE            EC=1.1.1.-;
DE   AltName: Full=All-trans and 9-cis retinol dehydrogenase;
DE   AltName: Full=Short chain dehydrogenase/reductase family 7C member 2;
GN   Name=RDH12; Synonyms=SDR7C2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLN-161.
RC   TISSUE=Cerebellum, and Kidney;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S.,
RA   Sun H., Du H., Pepin K., Artiguenave F., Robert C., Cruaud C.,
RA   Bruels T., Jaillon O., Friedlander L., Samson G., Brottier P.,
RA   Cure S., Segurens B., Aniere F., Samain S., Crespeau H., Abbasi N.,
RA   Aiach N., Boscus D., Dickhoff R., Dors M., Dubois I., Friedman C.,
RA   Gouyvenoux M., James R., Madan A., Mairey-Estrada B., Mangenot S.,
RA   Martins N., Menard M., Oztas S., Ratcliffe A., Shaffer T., Trask B.,
RA   Vacherie B., Bellemere C., Belser C., Besnard-Gonnet M.,
RA   Bartol-Mavel D., Boutard M., Briez-Silla S., Combette S.,
RA   Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C., Muselet D.,
RA   Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P., Trybou A.,
RA   Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L.,
RA   Verdier J., Verdier-Discala C., Hillier L.W., Fulton L., McPherson J.,
RA   Matsuda F., Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W.,
RA   Quetier F., Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION.
RX   PubMed=12226107; DOI=10.1074/jbc.M208882200;
RA   Haeseleer F., Jang G.-F., Imanishi Y., Driessen C.A.G.G.,
RA   Matsumura M., Nelson P.S., Palczewski K.;
RT   "Dual-substrate specificity short chain retinol dehydrogenases from
RT   the vertebrate retina.";
RL   J. Biol. Chem. 277:45537-45546(2002).
RN   [6]
RP   VARIANTS LCA13 ASN-51; ILE-99; ASN-151; ASP-151; PRO-175 AND ALA-230.
RX   PubMed=15322982; DOI=10.1086/424889;
RA   Perrault I., Hanein S., Gerber S., Barbet F., Ducroq D., Dollfus H.,
RA   Hamel C., Dufier J.-L., Munnich A., Kaplan J., Rozet J.-M.;
RT   "Retinal dehydrogenase 12 (RDH12) mutations in Leber congenital
RT   amaurosis.";
RL   Am. J. Hum. Genet. 75:639-646(2004).
RN   [7]
RP   VARIANTS LCA13 MET-49 AND CYS-226.
RX   PubMed=15258582; DOI=10.1038/ng1394;
RA   Janecke A.R., Thompson D.A., Utermann G., Becker C., Huebner C.A.,
RA   Schmid E., McHenry C.L., Nair A.R., Rueschendorf F., Heckenlively J.,
RA   Wissinger B., Nuernberg P., Gal A.;
RT   "Mutations in RDH12 encoding a photoreceptor cell retinol
RT   dehydrogenase cause childhood-onset severe retinal dystrophy.";
RL   Nat. Genet. 36:850-854(2004).
RN   [8]
RP   VARIANTS RETINAL DYSTROPHY THR-47; MET-55; ILE-99; LYS-125; GLU-145;
RP   ASP-151; ILE-155; CYS-193; ASP-206; VAL-206; LEU-230; HIS-234;
RP   TRP-239; PRO-274 AND TYR-285, VARIANTS GLN-65; ASN-101; GLN-161 AND
RP   CYS-193, CHARACTERIZATION OF VARIANTS RETINAL DYSTROPHY THR-47;
RP   MET-55; ILE-99; LYS-125; GLU-145; ASP-151; ILE-155; CYS-193; ASP-206;
RP   VAL-206; LEU-230; HIS-234; TRP-239; PRO-274 AND TYR-285, AND
RP   CHARACTERIZATION OF VARIANT GLN-161.
RX   PubMed=16269441; DOI=10.1093/hmg/ddi411;
RA   Thompson D.A., Janecke A.R., Lange J., Feathers K.L., Hubner C.A.,
RA   McHenry C.L., Stockton D.W., Rammesmayer G., Lupski J.R., Antinolo G.,
RA   Ayuso C., Baiget M., Gouras P., Heckenlively J.R., den Hollander A.,
RA   Jacobson S.G., Lewis R.A., Sieving P.A., Wissinger B., Yzer S.,
RA   Zrenner E., Utermann G., Gal A.;
RT   "Retinal degeneration associated with RDH12 mutations results from
RT   decreased 11-cis retinal synthesis due to disruption of the visual
RT   cycle.";
RL   Hum. Mol. Genet. 14:3865-3875(2005).
RN   [9]
RP   VARIANT RP53 VAL-126.
RX   PubMed=19140180; DOI=10.1002/ajmg.a.32634;
RA   Benayoun L., Spiegel R., Auslender N., Abbasi A.H., Rizel L.,
RA   Hujeirat Y., Salama I., Garzozi H.J., Allon-Shalev S., Ben-Yosef T.;
RT   "Genetic heterogeneity in two consanguineous families segregating
RT   early onset retinal degeneration: the pitfalls of homozygosity
RT   mapping.";
RL   Am. J. Med. Genet. A 149:650-656(2009).
RN   [10]
RP   VARIANT RP53 ARG-76.
RX   PubMed=19956407;
RA   Aldahmesh M.A., Safieh L.A., Alkuraya H., Al-Rajhi A., Shamseldin H.,
RA   Hashem M., Alzahrani F., Khan A.O., Alqahtani F., Rahbeeni Z.,
RA   Alowain M., Khalak H., Al-Hazzaa S., Meyer B.F., Alkuraya F.S.;
RT   "Molecular characterization of retinitis pigmentosa in Saudi Arabia.";
RL   Mol. Vis. 15:2464-2469(2009).
RN   [11]
RP   VARIANTS VAL-79 AND GLN-161.
RX   PubMed=21602930; DOI=10.1371/journal.pone.0019458;
RA   Li L., Xiao X., Li S., Jia X., Wang P., Guo X., Jiao X., Zhang Q.,
RA   Hejtmancik J.F.;
RT   "Detection of variants in 15 genes in 87 unrelated Chinese patients
RT   with Leber congenital amaurosis.";
RL   PLoS ONE 6:E19458-E19458(2011).
CC   -!- FUNCTION: Exhibits an oxidoreductive catalytic activity towards
CC       retinoids. Most efficient as an NADPH-dependent retinal reductase.
CC       Displays high activity toward 9-cis and all-trans-retinol. Also
CC       involved in the metabolism of short-chain aldehydes. No steroid
CC       dehydrogenase activity detected. Might be the key enzyme in the
CC       formation of 11-cis-retinal from 11-cis-retinol during
CC       regeneration of the cone visual pigments.
CC       {ECO:0000269|PubMed:12226107}.
CC   -!- INTERACTION:
CC       Q93062:RBPMS; NbExp=3; IntAct=EBI-3916363, EBI-740322;
CC       Q93062-3:RBPMS; NbExp=3; IntAct=EBI-3916363, EBI-740343;
CC       P0CG48:UBC; NbExp=2; IntAct=EBI-3916363, EBI-3390054;
CC   -!- TISSUE SPECIFICITY: Widely expressed, mostly in eye, kidney,
CC       brain, skeletal muscle and stomach.
CC   -!- DISEASE: Leber congenital amaurosis 13 (LCA13) [MIM:612712]: A
CC       severe dystrophy of the retina, typically becoming evident in the
CC       first years of life. Visual function is usually poor and often
CC       accompanied by nystagmus, sluggish or near-absent pupillary
CC       responses, photophobia, high hyperopia and keratoconus.
CC       {ECO:0000269|PubMed:15258582, ECO:0000269|PubMed:15322982}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Retinitis pigmentosa 53 (RP53) [MIM:612712]: A retinal
CC       dystrophy belonging to the group of pigmentary retinopathies.
CC       Retinitis pigmentosa is characterized by retinal pigment deposits
CC       visible on fundus examination and primary loss of rod
CC       photoreceptor cells followed by secondary loss of cone
CC       photoreceptors. Patients typically have night vision blindness and
CC       loss of midperipheral visual field. As their condition progresses,
CC       they lose their far peripheral visual field and eventually central
CC       vision as well. {ECO:0000269|PubMed:19140180,
CC       ECO:0000269|PubMed:19956407}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the short-chain dehydrogenases/reductases
CC       (SDR) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK054835; BAB70811.1; -; mRNA.
DR   EMBL; AK315462; BAG37849.1; -; mRNA.
DR   EMBL; AL049779; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471061; EAW80951.1; -; Genomic_DNA.
DR   EMBL; BC025724; AAH25724.1; -; mRNA.
DR   CCDS; CCDS9787.1; -.
DR   RefSeq; NP_689656.2; NM_152443.2.
DR   UniGene; Hs.415322; -.
DR   UniGene; Hs.739915; -.
DR   ProteinModelPortal; Q96NR8; -.
DR   SMR; Q96NR8; -.
DR   BioGrid; 126895; 24.
DR   IntAct; Q96NR8; 5.
DR   MINT; MINT-3056571; -.
DR   STRING; 9606.ENSP00000267502; -.
DR   DrugBank; DB00162; Vitamin A.
DR   iPTMnet; Q96NR8; -.
DR   PhosphoSitePlus; Q96NR8; -.
DR   BioMuta; RDH12; -.
DR   DMDM; 116242750; -.
DR   MaxQB; Q96NR8; -.
DR   PaxDb; Q96NR8; -.
DR   PeptideAtlas; Q96NR8; -.
DR   PRIDE; Q96NR8; -.
DR   DNASU; 145226; -.
DR   Ensembl; ENST00000267502; ENSP00000267502; ENSG00000139988.
DR   Ensembl; ENST00000551171; ENSP00000449079; ENSG00000139988.
DR   GeneID; 145226; -.
DR   KEGG; hsa:145226; -.
DR   UCSC; uc001xjz.5; human.
DR   CTD; 145226; -.
DR   DisGeNET; 145226; -.
DR   GeneCards; RDH12; -.
DR   GeneReviews; RDH12; -.
DR   HGNC; HGNC:19977; RDH12.
DR   MalaCards; RDH12; -.
DR   MIM; 608830; gene.
DR   MIM; 612712; phenotype.
DR   neXtProt; NX_Q96NR8; -.
DR   OpenTargets; ENSG00000139988; -.
DR   Orphanet; 65; Leber congenital amaurosis.
DR   Orphanet; 791; Retinitis pigmentosa.
DR   PharmGKB; PA134864793; -.
DR   eggNOG; KOG1208; Eukaryota.
DR   eggNOG; COG1028; LUCA.
DR   GeneTree; ENSGT00760000119068; -.
DR   HOVERGEN; HBG078800; -.
DR   InParanoid; Q96NR8; -.
DR   KO; K11153; -.
DR   OMA; IAPSIRK; -.
DR   OrthoDB; EOG091G0FGA; -.
DR   PhylomeDB; Q96NR8; -.
DR   TreeFam; TF105429; -.
DR   BioCyc; MetaCyc:ENSG00000139988-MONOMER; -.
DR   BRENDA; 1.1.1.105; 2681.
DR   BRENDA; 1.1.1.300; 2681.
DR   Reactome; R-HSA-2453902; The canonical retinoid cycle in rods (twilight vision).
DR   GeneWiki; RDH12; -.
DR   GenomeRNAi; 145226; -.
DR   PRO; PR:Q96NR8; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000139988; -.
DR   CleanEx; HS_RDH12; -.
DR   ExpressionAtlas; Q96NR8; baseline and differential.
DR   Genevisible; Q96NR8; HS.
DR   GO; GO:0005622; C:intracellular; IDA:UniProtKB.
DR   GO; GO:0060342; C:photoreceptor inner segment membrane; TAS:Reactome.
DR   GO; GO:0052650; F:NADP-retinol dehydrogenase activity; TAS:Reactome.
DR   GO; GO:0004745; F:retinol dehydrogenase activity; IDA:UniProtKB.
DR   GO; GO:0045494; P:photoreceptor cell maintenance; TAS:UniProtKB.
DR   GO; GO:0050896; P:response to stimulus; IEA:UniProtKB-KW.
DR   GO; GO:0001523; P:retinoid metabolic process; TAS:Reactome.
DR   GO; GO:0042572; P:retinol metabolic process; IDA:UniProtKB.
DR   GO; GO:0007601; P:visual perception; TAS:UniProtKB.
DR   InterPro; IPR016040; NAD(P)-bd_dom.
DR   InterPro; IPR002347; SDR_fam.
DR   Pfam; PF00106; adh_short; 1.
DR   PRINTS; PR00081; GDHRDH.
DR   PRINTS; PR00080; SDRFAMILY.
DR   SUPFAM; SSF51735; SSF51735; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Disease mutation; Leber congenital amaurosis; NADP;
KW   Oxidoreductase; Polymorphism; Reference proteome;
KW   Retinitis pigmentosa; Sensory transduction; Vision.
FT   CHAIN         1    316       Retinol dehydrogenase 12.
FT                                /FTId=PRO_0000054766.
FT   NP_BIND      46     52       NADP. {ECO:0000250}.
FT   ACT_SITE    200    200       Proton acceptor. {ECO:0000250}.
FT   BINDING     175    175       Substrate. {ECO:0000250}.
FT   VARIANT      47     47       A -> T (in retinal dystrophy; exhibits a
FT                                profound loss of catalytic activity;
FT                                dbSNP:rs761231974).
FT                                {ECO:0000269|PubMed:16269441}.
FT                                /FTId=VAR_064163.
FT   VARIANT      49     49       T -> M (in LCA13; aberrant activity in
FT                                interconverting isomers of retinol and
FT                                retinal; there is differing activity
FT                                profiles associated with each of the
FT                                alleles of the R-161-Q polymorphism;
FT                                genetic background may act as a modifier
FT                                of mutation effect; dbSNP:rs28940314).
FT                                {ECO:0000269|PubMed:15258582}.
FT                                /FTId=VAR_020858.
FT   VARIANT      51     51       I -> N (in LCA13; dbSNP:rs104894473).
FT                                {ECO:0000269|PubMed:15322982}.
FT                                /FTId=VAR_020859.
FT   VARIANT      55     55       T -> M (in retinal dystrophy; exhibits a
FT                                profound loss of catalytic activity;
FT                                dbSNP:rs766631462).
FT                                {ECO:0000269|PubMed:16269441}.
FT                                /FTId=VAR_064164.
FT   VARIANT      65     65       R -> Q (in dbSNP:rs745471670).
FT                                {ECO:0000269|PubMed:16269441}.
FT                                /FTId=VAR_064165.
FT   VARIANT      76     76       G -> R (in RP53; dbSNP:rs368489658).
FT                                {ECO:0000269|PubMed:19956407}.
FT                                /FTId=VAR_064166.
FT   VARIANT      79     79       A -> V (found in a patient with LCA13;
FT                                dbSNP:rs763414313).
FT                                {ECO:0000269|PubMed:21602930}.
FT                                /FTId=VAR_067193.
FT   VARIANT      99     99       L -> I (in LCA13; exhibits a profound
FT                                loss of catalytic activity;
FT                                dbSNP:rs28940315).
FT                                {ECO:0000269|PubMed:15322982,
FT                                ECO:0000269|PubMed:16269441}.
FT                                /FTId=VAR_020860.
FT   VARIANT     101    101       D -> N (in dbSNP:rs148334092).
FT                                {ECO:0000269|PubMed:16269441}.
FT                                /FTId=VAR_064167.
FT   VARIANT     125    125       N -> K (in retinal dystrophy; exhibits a
FT                                profound loss of catalytic activity).
FT                                {ECO:0000269|PubMed:16269441}.
FT                                /FTId=VAR_064168.
FT   VARIANT     126    126       A -> V (in RP53; dbSNP:rs202126574).
FT                                {ECO:0000269|PubMed:19140180}.
FT                                /FTId=VAR_064169.
FT   VARIANT     145    145       G -> E (in retinal dystrophy; exhibits a
FT                                profound loss of catalytic activity).
FT                                {ECO:0000269|PubMed:16269441}.
FT                                /FTId=VAR_064170.
FT   VARIANT     151    151       H -> D (in LCA13; exhibits a profound
FT                                loss of catalytic activity;
FT                                dbSNP:rs104894475).
FT                                {ECO:0000269|PubMed:15322982,
FT                                ECO:0000269|PubMed:16269441}.
FT                                /FTId=VAR_020861.
FT   VARIANT     151    151       H -> N (in LCA13; dbSNP:rs104894475).
FT                                {ECO:0000269|PubMed:15322982}.
FT                                /FTId=VAR_020862.
FT   VARIANT     155    155       T -> I (in retinal dystrophy; exhibits a
FT                                profound loss of catalytic activity;
FT                                dbSNP:rs121434337).
FT                                {ECO:0000269|PubMed:16269441}.
FT                                /FTId=VAR_064171.
FT   VARIANT     161    161       R -> Q (in dbSNP:rs17852293).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:16269441,
FT                                ECO:0000269|PubMed:21602930}.
FT                                /FTId=VAR_028281.
FT   VARIANT     175    175       S -> P (in LCA13; dbSNP:rs104894472).
FT                                {ECO:0000269|PubMed:15322982}.
FT                                /FTId=VAR_020863.
FT   VARIANT     193    193       R -> C (in retinal dystrophy; unknown
FT                                pathological significance;
FT                                dbSNP:rs148629905).
FT                                {ECO:0000269|PubMed:16269441}.
FT                                /FTId=VAR_064172.
FT   VARIANT     206    206       A -> D (in retinal dystrophy; exhibits a
FT                                profound loss of catalytic activity).
FT                                {ECO:0000269|PubMed:16269441}.
FT                                /FTId=VAR_064173.
FT   VARIANT     206    206       A -> V (in retinal dystrophy; unknown
FT                                pathological significance).
FT                                {ECO:0000269|PubMed:16269441}.
FT                                /FTId=VAR_064174.
FT   VARIANT     226    226       Y -> C (in LCA13; diminished activity in
FT                                interconverting isomers of retinol and
FT                                retinal; dbSNP:rs28940313).
FT                                {ECO:0000269|PubMed:15258582}.
FT                                /FTId=VAR_020864.
FT   VARIANT     230    230       P -> A (in LCA13; dbSNP:rs104894476).
FT                                {ECO:0000269|PubMed:15322982}.
FT                                /FTId=VAR_020865.
FT   VARIANT     230    230       P -> L (in retinal dystrophy; unknown
FT                                pathological significance).
FT                                {ECO:0000269|PubMed:16269441}.
FT                                /FTId=VAR_064175.
FT   VARIANT     234    234       R -> H (in retinal dystrophy; unknown
FT                                pathological significance; exhibits a
FT                                loss of catalytic activity;
FT                                dbSNP:rs750636662).
FT                                {ECO:0000269|PubMed:16269441}.
FT                                /FTId=VAR_064176.
FT   VARIANT     239    239       R -> W (in retinal dystrophy; exhibits a
FT                                profound loss of catalytic activity;
FT                                dbSNP:rs751589863).
FT                                {ECO:0000269|PubMed:16269441}.
FT                                /FTId=VAR_064177.
FT   VARIANT     274    274       L -> P (in retinal dystrophy; exhibits a
FT                                profound loss of catalytic activity).
FT                                {ECO:0000269|PubMed:16269441}.
FT                                /FTId=VAR_064178.
FT   VARIANT     285    285       C -> Y (in retinal dystrophy; exhibits a
FT                                profound loss of catalytic activity).
FT                                {ECO:0000269|PubMed:16269441}.
FT                                /FTId=VAR_064179.
SQ   SEQUENCE   316 AA;  35094 MW;  EA0915E1E484879B CRC64;
     MLVTLGLLTS FFSFLYMVAP SIRKFFAGGV CRTNVQLPGK VVVITGANTG IGKETARELA
     SRGARVYIAC RDVLKGESAA SEIRVDTKNS QVLVRKLDLS DTKSIRAFAE GFLAEEKQLH
     ILINNAGVMM CPYSKTADGF ETHLGVNHLG HFLLTYLLLE RLKVSAPARV VNVSSVAHHI
     GKIPFHDLQS EKRYSRGFAY CHSKLANVLF TRELAKRLQG TGVTTYAVHP GVVRSELVRH
     SSLLCLLWRL FSPFVKTARE GAQTSLHCAL AEGLEPLSGK YFSDCKRTWV SPRARNNKTA
     ERLWNVSCEL LGIRWE
//
